Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Vrtala

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
International Archives of Allergy and Immunology|April 4, 2013
Allergen content and in vivo allergenic activity of house dust mite extractsAnne Casset, Rudolf Valenta, Susanne Vrtala
Methods (San Diego, Calif.)|August 6, 2013
Recombinant house dust mite allergensSusanne Vrtala, Hans Huber, Wayne R Thomas
Molecular Immunology|April 29, 2023
House dust mite allergy: The importance of house dust mite allergens for diagnosis and immunotherapyHuey-Jy Huang, Eszter Sarzsinszky, Susanne Vrtala
The Journal of Investigative Dermatology|February 21, 2022
Response to González-Pérez et alPia Gattinger, Huey-Jy Huang, Rudolf Valenta, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responsesCornelia Egger, Friedrich Horak, Susanne Vrtala, et al.
Methods (San Diego, Calif.)|February 14, 2004
Strategies for converting allergens into hypoallergenic vaccine candidatesSusanne Vrtala, Margarete Focke-Tejkl, Ines Swoboda, et al.
Current Opinion in Allergy and Clinical Immunology|December 28, 2020
Novel vaccines for allergen-specific immunotherapyOluwatoyin Akinfenwa, Azahara Rodríguez-Domínguez, Susanne Vrtala, et al.
The Journal of Allergy and Clinical Immunology|May 10, 2015
Different IgE recognition of mite allergen components in asthmatic and nonasthmatic childrenYvonne Resch, Sven Michel, Michael Kabesch, et al.
Vaccine|January 11, 2011
Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccinationSusanne Vrtala, Monika Fohr, Raffaela Campana, et al.
Biological Chemistry|July 17, 2008
A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6Birgit Linhart, Nadine Mothes-Luksch, Susanne Vrtala, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
International Archives of Allergy and Immunology|April 4, 2013
Allergen content and in vivo allergenic activity of house dust mite extractsAnne Casset, Rudolf Valenta, Susanne Vrtala
Methods (San Diego, Calif.)|August 6, 2013
Recombinant house dust mite allergensSusanne Vrtala, Hans Huber, Wayne R Thomas
Molecular Immunology|April 29, 2023
House dust mite allergy: The importance of house dust mite allergens for diagnosis and immunotherapyHuey-Jy Huang, Eszter Sarzsinszky, Susanne Vrtala
The Journal of Investigative Dermatology|February 21, 2022
Response to González-Pérez et alPia Gattinger, Huey-Jy Huang, Rudolf Valenta, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responsesCornelia Egger, Friedrich Horak, Susanne Vrtala, et al.
Methods (San Diego, Calif.)|February 14, 2004
Strategies for converting allergens into hypoallergenic vaccine candidatesSusanne Vrtala, Margarete Focke-Tejkl, Ines Swoboda, et al.
Current Opinion in Allergy and Clinical Immunology|December 28, 2020
Novel vaccines for allergen-specific immunotherapyOluwatoyin Akinfenwa, Azahara Rodríguez-Domínguez, Susanne Vrtala, et al.
The Journal of Allergy and Clinical Immunology|May 10, 2015
Different IgE recognition of mite allergen components in asthmatic and nonasthmatic childrenYvonne Resch, Sven Michel, Michael Kabesch, et al.
Vaccine|January 11, 2011
Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccinationSusanne Vrtala, Monika Fohr, Raffaela Campana, et al.
Biological Chemistry|July 17, 2008
A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6Birgit Linhart, Nadine Mothes-Luksch, Susanne Vrtala, et al.
Pageof 9